KAUFX
Price
$6.19
Change
+$0.05 (+0.81%)
Updated
Jul 25 closing price
Net Assets
5.13B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

KAUFX vs PMAQX

Header iconKAUFX vs PMAQX Comparison
Open Charts KAUFX vs PMAQXBanner chart's image
Federated Hermes Kaufmann R
Price$6.19
Change+$0.05 (+0.81%)
VolumeN/A
Net Assets5.13B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
KAUFX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KAUFX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAUFX is a StrongBuy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. KAUFX (5.13B). PMAQX pays higher dividends than KAUFX: PMAQX (0.19) vs KAUFX (0.00). KAUFX was incepted earlier than PMAQX: KAUFX (39 years) vs PMAQX (9 years). KAUFX (2.22) is less costly to investors than PMAQX (0.59). KAUFX is a more actively managed with annual turnover of: 34.00 vs. PMAQX (10.50). KAUFX (0) and PMAQX (0) have matching initial minimum investment requirements. PMAQX annual gain was more profitable for investors over the last year : 13.16 vs. KAUFX (6.97). PMAQX return over 5 years is better than : 57.67 vs. KAUFX (-10.89).
KAUFXPMAQXKAUFX / PMAQX
Total Expense Ratio1.960.59332%
Annual Report Gross Expense Ratio2.220.59376%
Fund Existence39 years9 years-
Gain YTD10.8307.977136%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.13B33B16%
Annual Yield % from dividends0.000.19-
Returns for 1 year6.9713.1653%
Returns for 3 years28.7249.7658%
Returns for 5 years-10.8957.67-19%
Returns for 10 years-6.26N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics